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Abstract
In contrast with normal subjects where IgA is the main immunoglobulin in the intestine, patients with active inflammatory bowel disease (IBD) produce high concentrations of IgG from intestinal lymphocytes, but the antigens at which these antibodies are directed are unknown. To investigate the specificities of these antibodies mucosal immunoglobulins were isolated from washings taken at endoscopy from 21 control patients with irritable bowel syndrome, 10 control patients with intestinal inflammation due to infection or ischaemia, and 51 patients with IBD: 24 Crohn's disease (CD, 15 active, nine quiescent), 27 ulcerative colitis (UC, 20 active, seven inactive). Total mucosal IgG was much higher (p<0 001) in active UC (median 512 jxg/ml) and active CD (256 ,ug/ml) than in irritable bowel syndrome controls (1. 43 ,ug/ml), but not significantly different from controls with non-IBD intestinal inflammation (224 ,ug/ml). Mucosal IgG bound to proteins ofa range ofnon-pathogenic commensal faecal bacteria in active CD; this was higher than in UC (p<0.01); and both were significantly greater than controls with non-IBD intestinal inflammation (CD p<0001, UC p<001) or IBS (p<0*001 CD and UC). This mucosal IgG binding was shown on western blots and by enzyme linked immunosorbent assay (ELISA) to be principally directed against the bacterial cytoplasmic rather than the membrane proteins. Total mucosal IgA concentrations did not differ between IBD and controls, but the IgA titres against faecal bacteria were lower in UC than controls (p<0.01). These experiments show that there is an exaggerated mucosal immune response particularly in active CD but also in UC directed against cytoplasmic proteins of bacteria within the intestinal lumen; this implies that in relapse of IBD there is a breakdown of tolerance to the normal commensal flora of the gut. (Gut 1996; 38: 365-375) Keywords: inflammatory bowel disease, mucosal antibodies, intestinal bacteria.
The aetiologies of ulcerative colitis (UC) and Crohn's disease (CD) are unclear. There are a number of suggestions of possible environmental or genetical causes including persistent infections, vasculitis, and immunological abnormalities (including autoimmunity). It is thought that CD and UC have different aetiologies on the basis of differences in location, the macroscopic and microscopic appearance of the disorders, and differences in mucosal immune activation (resulting in different cytokine and immunoglobulin isotype profiles). Despite this the two disorders may have very similar presentations and precipitants of clinical relapse.' 2 We have previously shown that during relapse of CD intestinal permeability is increased3-5 allowing access of luminal constituents to the mucosa. The acute inflammatory response is, however, quantitatively an order of magnitude greater than in other conditions with similarly increased intestinal permeability.5 This is probably caused by increased intestinal immune responsiveness caused by the underlying disease. The importance of the interaction between luminal antigens and the mucosal immune system as the mechanism of relapse in inflammatory bowel disease (IBD) is suggested by the following findings.
(1) Known causes of relapse (intestinal infections, non-steroidal anti-inflammatory drugs, and stress) all increase permeability across the epithelial cell layer or have the potential to do so.5 6 Moreover, normal intestinal permeability in patients with CD predicts a long remission, whereas increased permeability heralds relapse.4 7 (2) Active CD can be treated by faecal stream In this paper we have directly tested the hypothesis that there is an abnormally increased mucosal immune response against non-pathogenic commensal intestinal bacteria in active CD and UC. Previous studies of circulating antibodies in serum samples of IBD patients initially proposed that there were high titres against enterobacteria (cross reactive with colonic mucins,14 but serum titres were subsequently shown not to be significantly different from control patients. '5-17 Similarly the proposal of enterobacterial antigen specific activation of peripheral blood lymphocytes18 was not confirmed. 19 However circulating immunoglobulin specificities may be unrepresentative of locally produced mucosal immunoglobulins. IgA is the main immunoglobulin produced in the intestinal mucosa of normal subjects, but in patients with active UC or CD both immunohistochemistry and cultured mucosal lymphocytes show that IgG production is dramatically increased (IgG, and IgG3 in UC; IgGQ, IgG,, and IgG, in CD20-26).
The antigens against which these mucosal immunoglobulins are directed have received comparatively little attention, except that monoclonal antibodies generated from mesenteric lymph nodes of IBD patients showed a higher frequency of binding to commensal intestinal bacteria in CD than in UC although control data could not be obtained. 27 We report the isolation of immunoglobulins directly from the intestinal mucosa of patients with IBD and control subjects with and without intestinal inflammation and characterisation of their antigen specificity against non-pathogenic commensal intestinal bacteria.
Methods

Patients
Patients were studied while undergoing colonoscopy or flexible sigmoidoscopy to investigate lower abdominal pain and changed bowel habit, or to define the extent or activity of known IBD. The diagnoses of UC (n=27) and CD (n=24) were made on standard criteria,28 29 
Isolation of intestinal mucosal immunoglobulin
The colonic mucosa was washed under direct vision with 100 ml 0.9% (w/v) saline injected through the flush channel of an Olympus CF200HL videocolonoscope or flexible sigmoidoscope, with the patient positioned to ensure that the relevant colonic segment was in a dependent position. Great care was taken to aspirate any fluid encountered in the colon during insertion of the colonoscope, and washings were only taken during withdrawal of the instrument so virtually all the wash fluid was aspirated (median 88 ml, range 72-96 ml). The wash fluid was aspirated after two minutes through the suction channel, and immediately aliquoted into 10 ml 1 mrM-phenylmethylsulphonylfluoride and 0-2 ml 500 mM EDTA (pH 8 Fig 2) . In patients with active CD and UC total IgG was significantly increased compared with irritable bowel control subjects (medians CD=256 ,ug/ml, UC=512 ,ug/ml; p<0001 for both). IgG Fig 3B) .
In contrast with the results with intestinal bacteria, measurements of mucosal immunoglobulin titres in IBD patients and controls using the non-intestinal bacteria S epidermidis (Fig 4) There were strong mucosal IgA titres in both groups of control patients against proteins from commensal intestinal bacteria (Fig 5) Figure 4 : ELISA of immunoglobulin samples obtained by colonoscopic washingfrom control (irritable bowel syndrome n =12; inflamed controls n =10), and active IBD patients (CD n=13; UC n=14) against membrane proteins of S epidermidis. Details were as described in the legend to Figure 3 except that plates were coated with a protein preparation of a non-pathogenic isolate of S epidermidis. Results were expressed in arbitrary IgG ELISA units calculatedfrom the S epidermidis standard calibrant per ,ug of total IgG. or H influenzae in any of the patient groups (not shown).
Mucosal antibody binding to cytoplasmic and membrane proteins of E coli To investigate further the bacterial proteins bound by mucosal immunoglobulins in patients with IBD, we carried out the following experiments.
(1) ELISA assays were performed to assess mucosal immunoglobulin binding to the individual bacterial membrane or cytoplasmic protein fractions.
(2) Western blots were run in which cytoplasmic or membrane proteins were loaded en bloc from a single large well, and the nitrocellulose was cut into strips after electrophoretic transfer, thus there was an identical amount of each E coli cytoplasmic or membrane protein band on every strip, which could be used to detect binding of immunoglobulins in individual mucosal or serum patient samples.
Both these techniques gave similar results. The ELISA assays showed that there was significantly greater binding of mucosal IgG in active CD to the cytoplasmic proteins than to the membrane fraction (p<000 1; Fig 6A) , however low concentrations of serum immunoglobulin bound to both bacterial cytoplasmic and membrane protein fractions (Fig 6B) . Fig 7A) . A single prominent * band at Mr 59 000 on the E coli cytoplasmic p < 0.001 proteins in controls and UC patients was not due to binding of mucosal immunoglobulin, as r it was also seen in blank strips to which no mucosal immunoglobulin had been added *~ (Fig 7A) 
